Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alnylam prepares to land first RNAi drug approval.

Literature DB >> 29487392

Alnylam prepares to land first RNAi drug approval.

Chris Morrison.

Abstract

Mesh：

Substances：
RNA, Small Interfering

Year: 2018 PMID： 29487392 DOI： 10.1038/nrd.2018.20

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise.

Authors: Manisit Das; Sara Musetti; Leaf Huang
Journal: Nucleic Acid Ther Date: 2018-12-18 Impact factor: 5.486

2. Public biotech in 2017-the numbers.

Authors: Chris Morrison; Riku Lähteenmäki
Journal: Nat Biotechnol Date: 2018-07-06 Impact factor: 54.908

3. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.

Authors: Arienne Mirmiran; Caroline Schmitt; Thibaud Lefebvre; Hana Manceau; Raêd Daher; Vincent Oustric; Antoine Poli; Jean-Jacques Lacapère; Boualem Moulouel; Hervé Puy; Zoubida Karim; Katell Peoc'h; Hugo Lenglet; Sylvie Simonin; Jean-Charles Deybach; Gaël Nicolas; Laurent Gouya
Journal: Am J Hum Genet Date: 2019-01-31 Impact factor: 11.025

Alnylam prepares to land first RNAi drug approval.

1. RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise.

2. Public biotech in 2017-the numbers.

3. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.

Review 4. Current Advances in Adeno-Associated Virus-Mediated Gene Therapy to Prevent Acquired Hearing Loss.

5. Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

6. Ribonucleic Acid Sequence Characterization by Negative Electron Transfer Dissociation Mass Spectrometry.

Review 7. Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms.

Review 8. Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy.

9. Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag^®.

10. Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles.